Welcome to CDC stacks |
Stacks Logo
Advanced Search
Select up to three search categories and corresponding keywords using the fields to the right. Refer to the Help section for more detailed instructions.
 
 
Help
Clear All Simple Search
Advanced Search
Tuberculosis screening and international adoption
  • Published Date:
    1/3/18
  • Language:
    English
Filetype[PDF-200.34 KB]


Details:
No Related Documents.
You May Also Like:
  1. Guidelines for the Treatment of Latent Tuberculosis Infection: Recommendations from the National Tuberculosis Controllers Association and CDC, 2020
    Personal Author:
    Sterling, Timothy R.; Njie, Gibril; Zenner, Dominik; Cohn, David L.; Reves, Randall; Ahmed, Amina; Menzies, Dick; Horsburgh, C. Robert; Crane, Charles M.; Burgos, Marcos; LoBue, Philip; Winston, Carla A.; Belknap, Robert;
    Corporate Authors:
    National Tuberculosis Controllers Association.. National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention (U.S.). Division of Tuberculosis Elimination..
    Published Date:
    February 14 2020
    Source:
    MMWR Recomm Rep. 69(1):1-11
    Description:
    Comprehensive guidelines for treatment of latent tuberculosis infection (LTBI) among persons living in the United States were last published in 2000 (American Thoracic Society. CDC targeted tuberculin testing and treatment of latent tuberculosis infe...
    File Type:
    Filetype[PDF - 337.36 KB]
  2. Varicella in Adult Foreigners at a Referral Hospital, Central Tokyo, Japan, 2012–2016
    Personal Author:
    Takaya, Saho; Kutsuna, Satoshi; Katanami, Yuichi; Yamamoto, Kei; Takeshita, Nozomi; Hayakawa, Kayoko; Kato, Yasuyuki; Kanagawa, Shuzo; Ohmagari, Norio;
    Published Date:
    Jan 2020
    Source:
    Emerg Infect Dis. 26(1):114-117
    Description:
    We report a case series of varicella among adult foreigners at a referral hospital in central Tokyo, Japan, during 2012-2016. This series highlights differences in varicella vaccination schedules by country and epidemiology by climate and identifies ...
    File Type:
    Filetype[PDF - 845.18 KB]
  3. Changes in tuberculosis epidemiology, United States, 1993–2017
    Personal Author:
    Armstrong, Lori R.; Winston, Carla A.; Stewart, Brock; Tsang, Clarisse A.; Langer, Adam J.; Navin, Thomas R.;
    Published Date:
    July 01 2019
    Source:
    Int J Tuberc Lung Dis. 23(7):797-804
    Description:
    BACKGROUND:After a steady decline for 20 years, the pace of decline of TB incidence in the United States has slowed.METHODS:Trends in TB incidence rates and case counts since 1993 were analyzed using national US surveillance data. Patient characteris...
    File Type:
    Filetype[PDF - 506.60 KB]
  4. Nationwide Shortage of Tuberculin Skin Test Antigens: CDC Recommendations for Patient Care and Public Health Practice
    Published Date:
    June 21 2019
    Source:
    MMWR Morb Mortal Wkly Rep. 68(24):552-553
    Description:
    CDC is expecting a 3-10 month nationwide shortage of Aplisol, a product of Par Pharmaceuticals, and one of two purified-protein derivative (PPD) tuberculin antigens licensed by the Food and Drug Administration (FDA) for use in performing tuberculin s...
    File Type:
    Filetype[PDF - 62.70 KB]
  5. Nationwide shortage of tuberculin skin test antigens : CDC recommendations for patient care and public health practice
    Corporate Authors:
    Centers for Disease Control and Prevention (U.S.)
    Published Date:
    06/06/2019
    Series:
    HAN ; 420
    Description:
    Distributed via the CDC Health Alert NetworkJune 6, 2019, 1130 ET (11:30 AM ET)CDCHAN-00420The Centers for Disease Control and Prevention (CDC) is expecting a 3 to 10 month nationwide shortage of APLISOL®, a product of Par Pharmaceuticals. APLISOL®...
    File Type:
    Filetype[PDF - 310.59 KB]